Long-term safety data are still limited, especially regarding potential impacts on mental health and metabolic development during adolescence
Stochastic neuropeptide signals compete to calibrate the rate of satiation
While this supports weight loss, certain foods may intensify side effects like nausea, bloating, and constipation
There are some caveats people must pay out of pocket, or the medication is sold in a vial rather than a prefilled injector pen but doctors and patients say the changes are long overdue
Last month (May 2025), Novo Nordisk and Septerna, a San Francisco, California-based bio/pharmaceutical company focused on GCPRs, formed an exclusive global collaboration and license agreement to discover, develop, and commercialize oral small-molecule medicines for treating obesity, Type 2 diabetes, and other cardiometabolic diseases, in a deal worth up to $2.2 billion ($200 million upfront and near-term funding and $2 billion in milestone payments)
